Abstract. Cerebral amyloid angiopathy (CAA) is conspicuous for its association with Alzheimer disease (AD) and as a cause of lobar hemorrhages in the elderly, but its role in cerebral infarction is less clear. There is evidence that CAA may also be a risk factor for ischemic infarction in AD. To further investigate CAA as a risk factor for infarction, we studied 108 cases of recent cerebral or cerebellar infarction diagnosed in tissue samples obtained from surgical material. There were 69 males and 39 females with a mean age of 52 yr (range 1-86). The majority of biopsies were obtained from the frontal and parietal lobes. Radiological studies demonstrated a lesion confined to a vascular distribution in 12 of the 17 (71%) cases examined. Microscopic sections stained with hematoxylin and eosin revealed complete, organizing infarction in 107 cases with areas of coagulative necrosis, anoxic-ischemic neuronal injury, inflammation, macrophages, vascular proliferation, gliosis, and swollen axons. One case showed an incomplete infarct. Most cases also exhibited a minor hemorrhagic component with hemosiderin and hematoidin pigments. CAA, defined as amyloid deposition in the walls of leptomeningeal and parenchymal arteries, was found by immunohistochemical stains for beta amyloid in 14 (13%) cases of complete cerebral infarct. Cortical beta amyloid plaques were found by immunohistochemistry in 19 (17%) cases. Cerebral or cerebellar tissues containing cortex and leptomeninges obtained from 136 patients with a mean age of 52 yr (range 1-85) during surgical procedures for diagnosis of primary or metastatic neoplasms and demyelinating lesions were used as age-matched controls. In this control group, CAA was found in 5 (3.7%) and beta amyloid plaques in 19 (14%). The results indicate that CAA, but not beta amyloid plaque formation, is significantly more common in patients with ischemic cerebral infarction than in age-matched controls with nonvascular lesions (odds ratio 3.8; 95% confidence interval 1.3-10.9; p Ͻ 0.01). Our results indicate that CAA is a risk factor for ischemic cerebral infarction in the population studied.
INTRODUCTION
Patients with Alzheimer disease (AD) and cognitively normal elderly subjects may develop a progressive accumulation of amyloid in the brain as a component of neuritic plaques or as mural deposits in the walls of medium-size and small arteries and arterioles within the meninges and cerebral cortex. The latter is known as cerebral amyloid angiopathy (CAA) (1, 2) . A major component of this type of amyloid is a peptide of 39-43 amino acids (beta amyloid), which is cleaved from the larger amyloid precursor protein. The majority of cases of CAA are sporadic, although rare familial variants have been described (3) . Affected blood vessels show thickened walls containing deposits of amorphous, eosinophilic, Congo red-positive and birefringent amyloid in the tunica media and adventitia. Formation of microaneurysms and fibrinoid necrosis may also be present (4) . CAA is a well-known cause of lobar hemorrhages in the elderly and has been observed in patients with ischemic cerebral infarctions (5) (6) (7) (8) . One study in patients with AD found that CAA was associated with increased prevalence of ischemic cerebral infarction at autopsy (9, 10) . To further investigate if CAA is a risk factor for ischemic brain infarction, we designed a case-control study that included 108 cases of patients with pathological diagnosis of cerebral or cerebellar infarction and 136 control patients with non-vascular lesions who underwent craniotomy and sampling of a space-occupying lesion. The cases were submitted for consultation to the Armed Forces Institute of Pathology (AFIP) from 1970 through 1997. The results indicate that CAA is a risk factor for ischemic cerebral infarction in the population we studied.
MATERIALS AND METHODS

Selection of Cases and Controls
Using Sample Power 1.0 (SPSS Inc., Chicago, IL), it was determined that a study with 110 cases and 140 controls has a power of 85% to detect differences of 15% in the prevalence of CAA. The repository of the AFIP was searched for surgical specimens of cerebral infarction (cases) and other non-vascular lesions (controls) using PANLARS (Pathology Natural Language Retrieval System). The initial group for analysis comprised 146 cases. Of this group, relevant clinical information, microscopic slide sections, and paraffin blocks with tissue were available in 108 cases, which were selected for study. In all cases microscopic slide sections stained with hematoxylin and eosin (H & E) were available for review. Additional special stains were available in selected cases including Bielschowsky or Bodian for nerve fibers, Luxol fast blue for myelin, Prussian blue for iron, Masson's trichrome, van Giesson for elastic fibers, 
Immunohistochemistry
One paraffin block from each case and corresponding controls containing meningeal vessels and/or cerebral cortex was selected to study the presence of CAA by immunohistochemistry. Consecutive 5-m-thick sections were obtained from each paraffin block. One microscopic section was stained with H & E. The other tissue sections were deparaffinized with xylene and immunostained using a 3-step streptavidin-peroxidase technique at room temperature with reagents commercially available from Biogenex (San Ramon, CA). Non-specific binding was reduced by blocking with Biogenex blocking solution for 10 minutes (min), and endogenous peroxidase activity was reduced by pre-incubation with 3% H 2 O 2 for 10 min. Slides were incubated with 98% formic acid for 3 min prior to immunostaining. The primary antibody was a 1:60 dilution of an IgG1 mouse monoclonal antibody raised against a synthetic peptide representing residues 8-17 of the beta amyloid molecule (NCLbeta amyloid, Novocastra, UK). The secondary reagent was a biotinylated goat antimouse polyclonal antibody, and the tertiary reagent was streptavidin labeled with horseradish peroxidase. The primary reagent was incubated for 30 min, and the secondary and tertiary reagents for 20 min. The chromogen was DAB (3,3 diaminobenzidine tetrahydrochloride) in 0.24% H 2 O 2 for 5 min, and the counterstaining was Mayer's hematoxylin for 1 min. All incubations were separated by 3 washes with OptiMax Wash buffer (Biogenex). Each staining run included positive and negative controls.
The slides were read independently by 2 neuropathologists and scored as positive or negative for the presence of beta amyloid staining in meningeal and parenchymal blood vessels and in diffuse or neuritic plaques. The density of amyloid plaques was recorded as sparse, moderate, and frequent following the guidelines proposed by the Consortium to Establish a Registry for Alzheimer Disease (CERAD) (12) . The location of the blood vessels involved by beta amyloid deposits was identified as leptomeningeal, parenchymal, or both. The density of leptomeningeal vessels was semiquantitatively scored from 0 to 3 as follows: 0 ϭ none; 1 ϭ sparse; 2 ϭ moderate; 3 ϭ frequent.
The amount of cortex and meningeal vessels present on each block used for the study was scored as none, small, moderate, and large.
Statistical Analysis
The null hypothesis of the study postulated that the frequency of CAA in cases of ischemic cerebral infarction and in agematched controls with non-vascular lesions would be the same. The criterion for significance was set at 0.05. The study power to yield a statistically significant result with 108 cases and 136 controls and a difference in proportions ofϪ0.15 was 85%. Data was analyzed using SPSS 9.0 (SPSS Inc.). Association of demographic and clinical variables with CAA was assessed by Yates-corrected Chi-square analysis. Multiple logistic regression analysis was used to study the effect of the size of stained tissues on the frequency of CAA. The initial logistic regression models were constructed using variables that were statistically significant at p ϭ 0.2 in the univariate analysis. Variables retained in the stepwise regression were significant at p ϭ 0.05.
RESULTS
Cases and Controls
The median age for the group of 108 cases was 52 yr (range 1-86 yr) ( Table 1) . Three patients were children aged 1, 6, and 7 yr, respectively. There were 69 (64%) males and 39 (36%) females, similar to controls. None of the patients had a history of dementia in the clinical summary submitted at the time of the initial diagnosis. All patients underwent a surgical procedure for biopsy or excision of a cerebral or cerebellar lesion suspected to be a neoplasm. The lesion was confined to a vascular territory in 12 of 17 cases in which the head CT or brain MRI were available for examination. The lesions were located in the frontal (35 cases), parietal (34 cases), occipital (12 cases), and temporal (8 cases) lobes (Table 1) . The cerebellum was the site of sampling in 13 cases. In 6 cases the location was unknown. The percentage of biopsies from the cerebellum was significantly larger in cases, and the percentage from the temporal lobe was significantly larger in controls (Table 1) . Microscopic examination showed fragments of gray matter in 101 (93.5%) cases and of white matter in only 7 (6.5%) cases. One hundred and seven (99%) cases showed lesions classified as complete infarction with areas of coagulative necrosis in 105 (97%), gliosis in 103 (95%), infiltration by macrophages in 102 (94.5%), vacuolation of the neuropil in 99 (92%), neovascularization in 96 (89%), presence of mononuclear inflammatory cells in 78 (72%), eosinophilic neurons in 63 (59%), and polymorphonuclear leucocytes in 28 (26%). In 1 case, the infarction was classified as incomplete, characterized by the presence of numerous eosinophilic neurons and absence of necrosis, macrophages, and inflammation (11) . Eighty (74%) complete infarctions contained foci of hemorrhages with deposition of hemosiderin and hematoidin pigments. This percentage increased to 86 when only cases positive for CAA were considered. In 17 (16%) cases thrombo-embolic occlusion of blood vessels of variable caliber by fibrin was observed. None of the cases demonstrated microorganisms or vasculitis. The classification of the various types of infarction will be correlated with the time frame between the initial clinical presentation, diagnosis, and evolution in a future communication.
Immunohistochemistry
Immunohistochemistry revealed beta amyloid deposition in the blood vessels in 14/108 cases of infarct (13%) ( Table 2 ; Fig. 1 ), involving leptomeningeal and cerebral parenchymal vessels in 10, leptomeningeal but not parenchymal vessels in 1, and parenchymal but not leptomeningeal vessels in 1 ( Table 3 ). In 2 cases only parenchymal blood vessels were present in the microscopic sections, so it is unknown if the leptomeningeal vessels were also positive for CAA. All blood vessels involved by CAA were found in the cerebrum and none in the cerebellum. The most common site was the parietal lobe in 6 cases, followed by the frontal and occipital lobes in 3 cases each, and the temporal lobe in 2 cases (Table 3) . The mean age for cases with CAA was 69.7 yr. CAA was not found in patients under the age of 54 yr. CAA was found in 5/136 (3.7%) controls, involving meningeal and parenchymal blood vessels in 3 cases, meningeal vessels only in 1 case, and parenchymal vessels only in 1 case. The blood vessels involved were from the frontal lobe in 4 cases and from the temporal lobe in 1 case. The mean age for patients with CAA in the control group was 68 yr. The youngest patient was 52 yr old. The difference in the frequency of CAA between cases (14/108 ϭ 13%) and controls (5/136 ϭ 3.7%) was statistically significant (p ϭ 0.01) ( Table 2) . Cortical neuritic plaques with beta amyloid deposition were found in 19 (17.6%) cases and in 19 (14%) controls (p ϭ 0.4) ( Table 2 ). When the percentage of combined beta amyloid deposition (in blood vessels or in brain parenchyma) was compared between cases and controls, the difference was not statistically significant (odds ratio 1.68, 95% confidence interval 0.86-3.3, p ϭ 0.13). The frequency of plaques, as defined by the CERAD criteria, was similar in cases and controls. The plaque morphology included diffuse and neuritic patterns in both cases and controls. Some patients with frequent plaques had no detectable CAA. None of the cases or controls fulfilled the CERAD criteria for a diagnosis of AD, as there was no clinical history of dementia. However, the retrospective nature of this study does not preclude the presence of subclinical dementia or AD.
These results indicate that CAA was significantly more frequent in cases with complete and incomplete cerebral infarction than in age-matched controls with non-vascular lesions. Patients with complete cerebral infarction were 3.8 times (95% confidence interval 1.3-10.9; p Ͻ 0.01) more likely to have CAA than those with non-vascular lesions. The odds ratio increases to 4.3 (95% confidence interval 1.53-12.8, p ϭ 0.003) if only adult patients (age Ͼ18 yr old) and cerebral tissue are included. The analysis of CAA per regions of the brain showed that the cerebellum was the only region that did not show deposition (Table 3 ). In the population studied, the percentage of biopsies from the cerebellum was higher in cases (12%) than in controls (2%) ( Table 1) . One possible explanation for a higher frequency of CAA in infarct cases than controls is the presence of a larger sample of meningeal and/ or parenchymal blood vessels in the paraffin blocks from cases of infarction. To evaluate this possibility, we estimated the amount of cerebral and cerebellar cortices and meningeal blood vessels present on each of the blocks used for this study (Table 4 ). The analysis showed that there was no difference in the amount of meningeal blood vessels between cases and controls. It also showed that the amount of cortices was larger in controls than in cases. We concluded that the higher frequency of CAA in cases of infarction could not be explained by an increased amount of blood vessels on sections from infarct cases. A logistic regression analysis revealed no association between the amount of blood vessels on tissue sections and the results of the immunostaining for CAA.
DISCUSSION
This study describes vascular ischemic lesions of the cerebrum and cerebellum in 108 cases in which surgical material was obtained from patients whose clinical presentation and neuroimaging studies suggested the presence of a space-occupying lesion. In 107 cases the microscopic examination showed complete infarction in several stages of evolution with coagulative necrosis, macrophages, inflammation, neovascularization, gliosis, neuronal ischemic injury and axonal swelling. In 1 case, in which the tissue samples showed cerebral cortex with acute neuronal injury and no necrosis or inflammation, the lesion was classified as incomplete infarction (11) . Complete infarctions were ischemic with foci of hemorrhage and deposition of blood pigments. The cause of the lesions was undetermined, although the presence of fibrin thrombi in the vascular lumens of some infarcts suggests the possibility of an occlusive phenomenon. Fourteen cases showed beta amyloid deposits in the walls of leptomeningeal and/or cortical arteries and arterioles of the cerebrum. Similar findings were also present in 5 of the age-matched controls. The statistical analysis indicated that CAA was significantly more common in the cases of cerebral infarction than in the controls (p Ͻ 0.01), with an odds ratio of 3.8 (95% confidence interval 1.3-10.9). In contrast, there was no significant difference in the frequency of beta amyloid plaques between cases and controls. This is the first time an association between CAA and ischemic cerebral infarction has been established, using surgical specimens as opposed to autopsy material, in patients with no clinical history of dementia at the time of diagnosis.
Several authors have noticed cortical cerebral ischemic infarctions in patients with CAA (6-8). Olichney et al studied the frequency of cerebral infarction in patients with AD and found that ischemic infarctions were more frequent in patients with severe than with mild or absent CAA (odds ratio 3.5; 95% confidence interval 1.4-8.9; p ϭ 0.006) (9) . Their study indicates that CAA is a risk factor for ischemic infarction in patients with AD. The OR increased to 14 when the frequency of cerebral infarction in cases of severe CAA with high blood pressure was compared to patients with mild to absent CAA and normal blood pressure, suggesting a synergistic effect between CAA and hypertension (9) . In hereditary cerebral hemorrhage with amyloidosis Dutch-type, an association between CAA and the number of cerebrovascular lesions was noticed, which was strongest in the presence of microaneurysmal degeneration (p Ͻ 0.001) (13) .
The risk factors for CAA include age (1), AD, the apolipoprotein E (Apo⑀) alleles 4 (Apo⑀ 4) (14, 15) and 2 (Apo⑀ 2) (16, 17) , alterations in cystatin C (18) , and family history in rare familial forms (3) . In an autopsy study in patients older than 60 yr in Japan, the frequency of CAA increased with age and reached 58% in patients over the age of 90 (19) . In other series, the prevalence of CAA decreased in frequency during the seventh and eighth decades of life (20) . We found CAA with complete cerebral infarction only in patients older than 54 yr. Some autopsy studies suggest that CAA may be more frequent in women than in men (19, 20) . In our age-matched series, there was no gender difference in the frequency of CAA between cases and controls.
The mechanism by which CAA increases the risk of ischemic infarction is unknown. One possibility is that the deposition of amyloid in the walls of meningeal and parenchymal arteries and arterioles induces a disturbance in the vascular reactivity to focal ischemia, with reduction in collateral circulation and more severe injury to ischemic tissues at risk for infarction (21) . Studies in a recently developed transgenic model of CAA (transgenic APP695.SWE) showed that overexpression of the amyloid precursor protein increases the susceptibility of the brain to ischemic injury (21) . In this model of experimental middle cerebral artery occlusion, ischemia did not result in increased expression of beta amyloid.
We found amyloid deposits in blood vessels and neuritic plaques in the cerebrum but none in the cerebellum. CAA was more frequently found in the frontal and parietal lobes, a distribution similar to that reported in an autopsy series of 653 patients from a general hospital in which CAA was more common in the frontal, parietal, and temporal regions (20) . In another study of 7 cases with severe CAA examined at autopsy, the temporal and occipital lobes were more often affected (19) . The prevalence of beta amyloid plaques of 17% and 14% in our surgical cases and controls, respectively, with a mean age of 52 yr, is within the range reported in autopsy studies.
In an autopsy study of 123 patients with malignant brain tumors, the prevalence of brain parenchymal beta amyloid deposition was 0%, 9.8%, and 21.5% in the fourth, fifth, and sixth decades, respectively (22) . In our study, 16/18 (89%) patients with CAA (13 cases and 5 controls) also had beta amyloid plaques. In autopsy series most if not all patients with CAA have associated cortical plaques (7, 19) . The finding of beta amyloid plaques in our study was insufficient to make a diagnosis of AD in any of the patients, since the clinical presentation did not include dementia.
The results of this and other studies indicate that CAA should be considered not only as a cause of lobar hemorrhage in the elderly and as a common manifestation of vasculopathy in patients with AD, but also as a risk factor for ischemic cerebral infarction.
